Coronavirus Vaccine Update: Positive Development For COVID-19 Vaccine
It has officially been more than six months since the COVID-19 pandemic, since it started to spread.
The rising number of cases across the world have paved the way for speedy clinical trials as the hunt for an effective vaccine or cure continues. Experts still suggest that it could take anywhere between 12-16 months for the world to get a ready vaccine to counter the virus. Even so, more than 110 groups around the world are in contention to manufacture a vaccine right now. Some have advanced to the second phase, while others are experimenting with alternative medicines. We give you an update on the latest round of development of the most promising vaccines right now.
Read also / Oxford University’s Covid-19 Vaccine Moves to Next Stage of Human Trial, Check here
The vaccine developed by Bharat Biotech International Limited in collaboration with Indian Council of Medical Research (ICMR) has shown positive development with lead researchers pinpointing the next month as the most “crucial” stage. While the makers haven’t let a word out on the status of human trials, they have high hopes on the working of the vaccine, which is modelled on building up the body’s immunity. In a statement given to IANS, CEO Dr Krishna Mohan Ella said, “The vaccine development is moving in a positive direction. The next month is very crucial. I am a scientist and I believe in science.”
Even though the latest developments are promising and first of a kind for any Indian company, it could take anywhere between 6-12 months before we see the vaccine ready and dosing starts.
Read also / Scientists in China believe new drug can stop pandemic ‘without vaccine’
Apart from this, there are seven other Indian vaccines in the works which have been okayed by the WHO, some of which are all set to proceed to the human clinical trial phase. Serum Institue of India, amongst them, has partnered with Oxford University in their vaccine clinical trials.
Read also / COVID19: Trump says coronavirus vaccine will be available by year’s end